Modification and implementation of NCCN guidelines on lymphomas in the Middle East and North Africa region.

Ali Bazarbachi; Hamdy A. Azim; Hussain Alizadeh; Mahmoud Aljurf; Ibrahim Barista; Naeem A. Chaudhri; Zahira Fahed; Omar A. Fahmy; Ardeshir Ghavamzadeh; Mohamed H. Khalaf; Sami Khatib; Aghiad Kutoubi; Semra Paydas; Hanadi Rafii Elayoubi; Ghazi Zaatari; Hamdy M. Zawam; Andrew D. Zelenetz; Lymphoma Regional Guidelines Committee MENA Lymphoma Regional Guidelines Committee

Modification and implementation of NCCN guidelines on lymphomas in the Middle East and North Africa region.

Ali Bazarbachi
, Hamdy A. Azim
, Hussain Alizadeh
, Mahmoud Aljurf
, Ibrahim Barista
, Naeem A. Chaudhri
, Zahira Fahed
, Omar A. Fahmy
, Ardeshir Ghavamzadeh
, Mohamed H. Khalaf
, Sami Khatib
, Aghiad Kutoubi
, Semra Paydas
, Hanadi Rafii Elayoubi
, Ghazi Zaatari
, Hamdy M. Zawam
, Andrew D. Zelenetz
, Lymphoma Regional Guidelines Committee MENA Lymphoma Regional Guidelines Committee

Division of Internal Medicine (Medicine)

American University of Beirut

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

Abstract

In the Middle East and North Africa (MENA) region, cancer has many epidemiologic and clinical features that are different from those in the rest of the world. Additionally, the region has a relatively young population and large disparities in the availability of resources at diagnostic and treatment levels. A critical need exists for regional guidelines on cancer care, including those for lymphoid malignancies. A panel of lymphoma experts from MENA reviewed the 2009 version of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) on Non-Hodgkin's Lymphoma and Hodgkin Lymphoma and suggested modifications for the region that were discussed with the United States NCCN Lymphoma Panels. This article presents the consensus recommendations.

Original language	English
Pages (from-to)	S29-35
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	8 Suppl 3
Publication status	Published - Jul 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

Bazarbachi, A., Azim, H. A., Alizadeh, H., Aljurf, M., Barista, I., Chaudhri, N. A., Fahed, Z., Fahmy, O. A., Ghavamzadeh, A., Khalaf, M. H., Khatib, S., Kutoubi, A., Paydas, S., Elayoubi, H. R., Zaatari, G., Zawam, H. M., Zelenetz, A. D., & MENA Lymphoma Regional Guidelines Committee, L. R. G. C. (2010). Modification and implementation of NCCN guidelines on lymphomas in the Middle East and North Africa region. JNCCN Journal of the National Comprehensive Cancer Network, 8 Suppl 3, S29-35.

@article{094913bf7454400d9e912468c800bc82,

title = "Modification and implementation of NCCN guidelines on lymphomas in the Middle East and North Africa region.",

abstract = "In the Middle East and North Africa (MENA) region, cancer has many epidemiologic and clinical features that are different from those in the rest of the world. Additionally, the region has a relatively young population and large disparities in the availability of resources at diagnostic and treatment levels. A critical need exists for regional guidelines on cancer care, including those for lymphoid malignancies. A panel of lymphoma experts from MENA reviewed the 2009 version of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) on Non-Hodgkin's Lymphoma and Hodgkin Lymphoma and suggested modifications for the region that were discussed with the United States NCCN Lymphoma Panels. This article presents the consensus recommendations.",

author = "Ali Bazarbachi and Azim, \{Hamdy A.\} and Hussain Alizadeh and Mahmoud Aljurf and Ibrahim Barista and Chaudhri, \{Naeem A.\} and Zahira Fahed and Fahmy, \{Omar A.\} and Ardeshir Ghavamzadeh and Khalaf, \{Mohamed H.\} and Sami Khatib and Aghiad Kutoubi and Semra Paydas and Elayoubi, \{Hanadi Rafii\} and Ghazi Zaatari and Zawam, \{Hamdy M.\} and Zelenetz, \{Andrew D.\} and \{MENA Lymphoma Regional Guidelines Committee\}, \{Lymphoma Regional Guidelines Committee\}",

year = "2010",

month = jul,

language = "English",

volume = "8 Suppl 3",

pages = "S29--35",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Harborside Press",

}

Bazarbachi, A, Azim, HA, Alizadeh, H, Aljurf, M, Barista, I, Chaudhri, NA, Fahed, Z, Fahmy, OA, Ghavamzadeh, A, Khalaf, MH, Khatib, S, Kutoubi, A, Paydas, S, Elayoubi, HR, Zaatari, G, Zawam, HM, Zelenetz, AD & MENA Lymphoma Regional Guidelines Committee, LRGC 2010, 'Modification and implementation of NCCN guidelines on lymphomas in the Middle East and North Africa region.', JNCCN Journal of the National Comprehensive Cancer Network, vol. 8 Suppl 3, pp. S29-35.

TY - JOUR

T1 - Modification and implementation of NCCN guidelines on lymphomas in the Middle East and North Africa region.

AU - Bazarbachi, Ali

AU - Azim, Hamdy A.

AU - Alizadeh, Hussain

AU - Aljurf, Mahmoud

AU - Barista, Ibrahim

AU - Chaudhri, Naeem A.

AU - Fahed, Zahira

AU - Fahmy, Omar A.

AU - Ghavamzadeh, Ardeshir

AU - Khalaf, Mohamed H.

AU - Khatib, Sami

AU - Kutoubi, Aghiad

AU - Paydas, Semra

AU - Elayoubi, Hanadi Rafii

AU - Zaatari, Ghazi

AU - Zawam, Hamdy M.

AU - Zelenetz, Andrew D.

AU - MENA Lymphoma Regional Guidelines Committee, Lymphoma Regional Guidelines Committee

PY - 2010/7

Y1 - 2010/7

N2 - In the Middle East and North Africa (MENA) region, cancer has many epidemiologic and clinical features that are different from those in the rest of the world. Additionally, the region has a relatively young population and large disparities in the availability of resources at diagnostic and treatment levels. A critical need exists for regional guidelines on cancer care, including those for lymphoid malignancies. A panel of lymphoma experts from MENA reviewed the 2009 version of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) on Non-Hodgkin's Lymphoma and Hodgkin Lymphoma and suggested modifications for the region that were discussed with the United States NCCN Lymphoma Panels. This article presents the consensus recommendations.

AB - In the Middle East and North Africa (MENA) region, cancer has many epidemiologic and clinical features that are different from those in the rest of the world. Additionally, the region has a relatively young population and large disparities in the availability of resources at diagnostic and treatment levels. A critical need exists for regional guidelines on cancer care, including those for lymphoid malignancies. A panel of lymphoma experts from MENA reviewed the 2009 version of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) on Non-Hodgkin's Lymphoma and Hodgkin Lymphoma and suggested modifications for the region that were discussed with the United States NCCN Lymphoma Panels. This article presents the consensus recommendations.

UR - https://www.scopus.com/pages/publications/79956190877

M3 - Article

C2 - 20697129

AN - SCOPUS:79956190877

SN - 1540-1405

VL - 8 Suppl 3

SP - S29-35

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

ER -

Modification and implementation of NCCN guidelines on lymphomas in the Middle East and North Africa region.

Abstract

UN SDGs

Other files and links

Fingerprint

Cite this